Skip to main content
Erschienen in: Clinical Research in Cardiology 2/2019

27.06.2018 | Review

Body mass index and all-cause mortality in heart failure patients with normal and reduced ventricular ejection fraction: a dose–response meta-analysis

verfasst von: Jufen Zhang, Aine Begley, Ruth Jackson, Michael Harrison, Pierpaolo Pellicori, Andrew L. Clark, John G. F. Cleland

Erschienen in: Clinical Research in Cardiology | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

For patients with heart failure, there is an inverse relation between body mass index (BMI) and mortality, sometimes called the obesity-paradox. However, the relationship might be either U- or J-shaped and might differ between patients with reduced (HFrEF) or preserved left ventricular ejection fraction (HFpEF). We sought to investigate this further in a dose–response meta-analysis of published studies.

Methods

PubMed and Embase from June 1980 to April 2017 were searched for prospective cohort studies evaluating associations between BMI and all-cause mortality in patients with HFrEF (LVEF < 40%) or HFpEF (LVEF ≥ 50%). Summary estimated effect sizes were obtained by using a random-effects model. Potential non-linear relationships were evaluated by using random-effects restricted cubic spline models.

Results

Ten studies were identified that included 96,424 patients of whom 59,263 had HFpEF (mean age 68 years of whom 38% were women) and 37,161 had HFrEF (mean age 60 years of whom 17% were women). For patients with HFpEF, the summary hazard ratio (HR) for all-cause mortality was: 0.93 (95% CI 0.89–0.97) per 5 units increase in BMI (I2 = 75.8%, p for heterogeneity = 0.01 and Begg’s test, p = 1.0, Egger’s test, p = 0.29) but the association was U-shaped (p for non-linearity < 0.01) with the nadir of risk at a BMI of 32–33 kg/m2. For patients with HFrEF, the summary HR for all-cause mortality was: 0.96 (95% CI 0.92–0.99) (I2 = 95%, p for heterogeneity < 0.001 and Begg’s test, p = 0.45, Egger’s test, p = 0.01). The relationship was also U-shaped (p < 0.01), although ‘flatter’ than for HFpEF, with the nadir at a BMI of 33 kg/m2.

Conclusions

For patients with heart failure, the relation between BMI and mortality is U-shaped with a similar nadir of risk for HFpEF and HFrEF at a BMI of 32–33 kg/m2. Whether interventions that alter weight in either direction can alter risk is unknown.
Literatur
1.
Zurück zum Zitat Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Woo MA, Tillisch JH (2001) The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol 38(3):789–95CrossRefPubMed Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Woo MA, Tillisch JH (2001) The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol 38(3):789–95CrossRefPubMed
2.
Zurück zum Zitat Osman AF, Mehra MR, Lavie CJ, Nunez E, Milani RV (2000) The incremental prognostic importance of body fat adjusted peak oxygen consumption in chronic heart failure. J Am Coll Cardiol 36(7):2126–2131CrossRefPubMed Osman AF, Mehra MR, Lavie CJ, Nunez E, Milani RV (2000) The incremental prognostic importance of body fat adjusted peak oxygen consumption in chronic heart failure. J Am Coll Cardiol 36(7):2126–2131CrossRefPubMed
3.
Zurück zum Zitat Kapoor JR, Heidenreich PA (2010) Obesity and survival in patients with heart failure and preserved systolic function: a U-shaped relationship. Am Heart J 159(1):75–80CrossRefPubMed Kapoor JR, Heidenreich PA (2010) Obesity and survival in patients with heart failure and preserved systolic function: a U-shaped relationship. Am Heart J 159(1):75–80CrossRefPubMed
4.
Zurück zum Zitat Oreopoulos A, Padwal R, Kalantar-Zadeh K, Fonarow GC, Norris CM, McAlister FA (2008) Body mass index and mortality in heart failure: a meta-analysis. Am Heart J 156(1):13–22CrossRefPubMed Oreopoulos A, Padwal R, Kalantar-Zadeh K, Fonarow GC, Norris CM, McAlister FA (2008) Body mass index and mortality in heart failure: a meta-analysis. Am Heart J 156(1):13–22CrossRefPubMed
5.
Zurück zum Zitat Zamora E, Lupon J, Urrutia A, Gonzalez B, Mas D, Pascual T, Domingo M, Valle V (2007) Does body mass index influence mortality in patients with heart failure?. Rev Esp Cardiol 60(11):1127–1134CrossRefPubMed Zamora E, Lupon J, Urrutia A, Gonzalez B, Mas D, Pascual T, Domingo M, Valle V (2007) Does body mass index influence mortality in patients with heart failure?. Rev Esp Cardiol 60(11):1127–1134CrossRefPubMed
6.
Zurück zum Zitat Shah RV, Murthy VL, Abbasi SA, Blankstein R, Kwong RY, Goldfine AB, Jerosch-Herold M, Lima JA, Ding J, Allison MA (2014) Visceral adiposity and the risk of metabolic syndrome across body mass index: the MESA Study. JACC Cardiovasc Imaging 7(12):1221–1235CrossRefPubMedPubMedCentral Shah RV, Murthy VL, Abbasi SA, Blankstein R, Kwong RY, Goldfine AB, Jerosch-Herold M, Lima JA, Ding J, Allison MA (2014) Visceral adiposity and the risk of metabolic syndrome across body mass index: the MESA Study. JACC Cardiovasc Imaging 7(12):1221–1235CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Clark AL, Coats AJS, Krum H, Katus HA, Mohacsi P, Salekin D, Schultz MK, Packer M, Anker SD (2017) Effect of beta-adrenergic blockade with carvedilol on cachexia in severe chronic heart failure: results from the COPERNICUS trial. J Cachexia Sarcopenia Muscle 8(4):549–556CrossRefPubMedPubMedCentral Clark AL, Coats AJS, Krum H, Katus HA, Mohacsi P, Salekin D, Schultz MK, Packer M, Anker SD (2017) Effect of beta-adrenergic blockade with carvedilol on cachexia in severe chronic heart failure: results from the COPERNICUS trial. J Cachexia Sarcopenia Muscle 8(4):549–556CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Padwal R, McAlister FA, McMurray JJ, Cowie MR, Rich M, Pocock S, Swedberg K, Maggioni A, Gamble G, Ariti C, Earle N, Whalley G, Poppe KK, Doughty RN, Bayes-Genis A (2014) Meta-analysis Global Group in Chronic Heart F. The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data. Int J Obes (Lond) 38(8):1110–1114CrossRef Padwal R, McAlister FA, McMurray JJ, Cowie MR, Rich M, Pocock S, Swedberg K, Maggioni A, Gamble G, Ariti C, Earle N, Whalley G, Poppe KK, Doughty RN, Bayes-Genis A (2014) Meta-analysis Global Group in Chronic Heart F. The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data. Int J Obes (Lond) 38(8):1110–1114CrossRef
9.
Zurück zum Zitat Somaratne JB, Berry C, McMurray JJ, Poppe KK, Doughty RN, Whalley GA (2009) The prognostic significance of heart failure with preserved left ventricular ejection fraction: a literature-based meta-analysis. Eur J Heart Fail 11(9):855–62CrossRefPubMed Somaratne JB, Berry C, McMurray JJ, Poppe KK, Doughty RN, Whalley GA (2009) The prognostic significance of heart failure with preserved left ventricular ejection fraction: a literature-based meta-analysis. Eur J Heart Fail 11(9):855–62CrossRefPubMed
10.
Zurück zum Zitat Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational Studies in Epidemiology (MOOSE) group. JAMA 283(15):2008–2012CrossRefPubMed Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational Studies in Epidemiology (MOOSE) group. JAMA 283(15):2008–2012CrossRefPubMed
11.
Zurück zum Zitat Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Open Med 3(3):e123-30PubMed Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Open Med 3(3):e123-30PubMed
12.
Zurück zum Zitat Organization WH (2009) Principles for modelling dose–response for the risk assessment of chemicals. World Health Organization, Geneva Organization WH (2009) Principles for modelling dose–response for the risk assessment of chemicals. World Health Organization, Geneva
13.
Zurück zum Zitat Shah R, Gayat E, Januzzi JL Jr, Sato N, Cohen-Solal A, diSomma S, Fairman E, Harjola VP, Ishihara S, Lassus J, Maggioni A, Metra M, Mueller C, Mueller T, Parenica J, Pascual-Figal D, Peacock WF, Spinar J, van Kimmenade R, Mebazaa A, Network G (2014) Body mass index and mortality in acutely decompensated heart failure across the world: a global obesity paradox. J Am Coll Cardiol 63(8):778–85CrossRefPubMed Shah R, Gayat E, Januzzi JL Jr, Sato N, Cohen-Solal A, diSomma S, Fairman E, Harjola VP, Ishihara S, Lassus J, Maggioni A, Metra M, Mueller C, Mueller T, Parenica J, Pascual-Figal D, Peacock WF, Spinar J, van Kimmenade R, Mebazaa A, Network G (2014) Body mass index and mortality in acutely decompensated heart failure across the world: a global obesity paradox. J Am Coll Cardiol 63(8):778–85CrossRefPubMed
14.
Zurück zum Zitat Bozkurt B, Deswal A (2005) Obesity as a prognostic factor in chronic symptomatic heart failure. Am Heart J 150(6):1233–1239CrossRefPubMed Bozkurt B, Deswal A (2005) Obesity as a prognostic factor in chronic symptomatic heart failure. Am Heart J 150(6):1233–1239CrossRefPubMed
15.
Zurück zum Zitat Hamaguchi S, Tsuchihashi-Makaya M, Kinugawa S, Goto D, Yokota T, Goto K, Yamada S, Yokoshiki H, Takeshita A, Tsutsui H, Investigators J-C (2010) Body mass index is an independent predictor of long-term outcomes in patients hospitalized with heart failure in Japan. Circ J 74(12):2605–2611CrossRefPubMed Hamaguchi S, Tsuchihashi-Makaya M, Kinugawa S, Goto D, Yokota T, Goto K, Yamada S, Yokoshiki H, Takeshita A, Tsutsui H, Investigators J-C (2010) Body mass index is an independent predictor of long-term outcomes in patients hospitalized with heart failure in Japan. Circ J 74(12):2605–2611CrossRefPubMed
16.
Zurück zum Zitat Greenland S, Longnecker MP (1992) Methods for trend estimation from summarized dose–response data, with applications to meta-analysis. Am J Epidemiol 135(11):1301–1309CrossRefPubMed Greenland S, Longnecker MP (1992) Methods for trend estimation from summarized dose–response data, with applications to meta-analysis. Am J Epidemiol 135(11):1301–1309CrossRefPubMed
17.
Zurück zum Zitat Orsini N, Li R, Wolk A, Khudyakov P, Spiegelman D (2012) Meta-analysis for linear and nonlinear dose–response relations: examples, an evaluation of approximations, and software. Am J Epidemiol 175(1):66–73CrossRefPubMed Orsini N, Li R, Wolk A, Khudyakov P, Spiegelman D (2012) Meta-analysis for linear and nonlinear dose–response relations: examples, an evaluation of approximations, and software. Am J Epidemiol 175(1):66–73CrossRefPubMed
18.
Zurück zum Zitat Orsini N (2009) From floated to conventional confidence intervals for the relative risks based on published dose–response data. Comput Methods Programs Biomed 88(1):90–93CrossRef Orsini N (2009) From floated to conventional confidence intervals for the relative risks based on published dose–response data. Comput Methods Programs Biomed 88(1):90–93CrossRef
19.
Zurück zum Zitat Clark AL, Fonarow GC, Horwich TB (2015) Impact of cardiorespiratory fitness on the obesity paradox in patients with systolic heart failure. Am J Cardiol 115(2):209–13CrossRefPubMed Clark AL, Fonarow GC, Horwich TB (2015) Impact of cardiorespiratory fitness on the obesity paradox in patients with systolic heart failure. Am J Cardiol 115(2):209–13CrossRefPubMed
20.
Zurück zum Zitat Orsini NBR, Greenland S (2006) Generalized least squares for trend estimation of summarized dose–response data. Stat J 6:40–57CrossRef Orsini NBR, Greenland S (2006) Generalized least squares for trend estimation of summarized dose–response data. Stat J 6:40–57CrossRef
21.
Zurück zum Zitat Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558CrossRefPubMed Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558CrossRefPubMed
22.
Zurück zum Zitat Begg CBMM. (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088–1101CrossRefPubMed Begg CBMM. (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088–1101CrossRefPubMed
24.
Zurück zum Zitat De Schutter A, Lavie CJ, Kachur S, Patel DA, Milani RV (2014) Body composition and mortality in a large cohort with preserved ejection fraction: untangling the obesity paradox. Mayo Clin Proc 89(8):1072–1079CrossRefPubMed De Schutter A, Lavie CJ, Kachur S, Patel DA, Milani RV (2014) Body composition and mortality in a large cohort with preserved ejection fraction: untangling the obesity paradox. Mayo Clin Proc 89(8):1072–1079CrossRefPubMed
25.
Zurück zum Zitat Wu AH, Eagle KA, Montgomery DG, Kline-Rogers E, Hu YC, Aaronson KD (2009) Relation of body mass index to mortality after development of heart failure due to acute coronary syndrome. Am J Cardiol 103(12):1736–1740CrossRefPubMed Wu AH, Eagle KA, Montgomery DG, Kline-Rogers E, Hu YC, Aaronson KD (2009) Relation of body mass index to mortality after development of heart failure due to acute coronary syndrome. Am J Cardiol 103(12):1736–1740CrossRefPubMed
26.
Zurück zum Zitat Vest AR, Wu Y, Hachamovitch R, Young JB, Cho L (2015) The heart failure overweight/obesity survival paradox: the missing sex link. JACC Heart Fail 3(11):917–26CrossRefPubMed Vest AR, Wu Y, Hachamovitch R, Young JB, Cho L (2015) The heart failure overweight/obesity survival paradox: the missing sex link. JACC Heart Fail 3(11):917–26CrossRefPubMed
27.
Zurück zum Zitat Haass M, Kitzman DW, Anand IS, Miller A, Zile MR, Massie BM, Carson PE (2011) Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial. Circ Heart Fail 4(3):324–31CrossRefPubMedPubMedCentral Haass M, Kitzman DW, Anand IS, Miller A, Zile MR, Massie BM, Carson PE (2011) Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial. Circ Heart Fail 4(3):324–31CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Curtis JP, Selter JG, Wang Y, Rathore SS, Jovin IS, Jadbabaie F, Kosiborod M, Portnay EL, Sokol SI, Bader F, Krumholz HM (2005) The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med 165(1):55–61CrossRefPubMed Curtis JP, Selter JG, Wang Y, Rathore SS, Jovin IS, Jadbabaie F, Kosiborod M, Portnay EL, Sokol SI, Bader F, Krumholz HM (2005) The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med 165(1):55–61CrossRefPubMed
29.
Zurück zum Zitat Zafrir B, Goren Y, Salman N, Amir O (2015) Comparison of body mass index and body surface area as outcome predictors in patients with systolic heart failure. Cardiol J 22(4):375–81CrossRefPubMed Zafrir B, Goren Y, Salman N, Amir O (2015) Comparison of body mass index and body surface area as outcome predictors in patients with systolic heart failure. Cardiol J 22(4):375–81CrossRefPubMed
30.
Zurück zum Zitat McAuley P, Myers J, Abella J, Froelicher V (2007) Body mass, fitness and survival in veteran patients: another obesity paradox? Am J Med 120(6):518–24CrossRefPubMed McAuley P, Myers J, Abella J, Froelicher V (2007) Body mass, fitness and survival in veteran patients: another obesity paradox? Am J Med 120(6):518–24CrossRefPubMed
31.
Zurück zum Zitat Alpert MA (2016) Severe obesity and acute decompensated heart failure: new insights into prevalence and prognosis. JACC Heart Fail 4(12):932–934CrossRefPubMed Alpert MA (2016) Severe obesity and acute decompensated heart failure: new insights into prevalence and prognosis. JACC Heart Fail 4(12):932–934CrossRefPubMed
32.
Zurück zum Zitat Agarwal SK, Chambless LE, Ballantyne CM, Astor B, Bertoni AG, Chang PP, Folsom AR, He M, Hoogeveen RC, Ni H, Quibrera PM, Rosamond WD, Russell SD, Shahar E, Heiss G (2012) Prediction of incident heart failure in general practice: the Atherosclerosis Risk in Communities (ARIC) Study. Circ Heart Fail 5(4):422–429CrossRefPubMedPubMedCentral Agarwal SK, Chambless LE, Ballantyne CM, Astor B, Bertoni AG, Chang PP, Folsom AR, He M, Hoogeveen RC, Ni H, Quibrera PM, Rosamond WD, Russell SD, Shahar E, Heiss G (2012) Prediction of incident heart failure in general practice: the Atherosclerosis Risk in Communities (ARIC) Study. Circ Heart Fail 5(4):422–429CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Miro O, Gil VI, Martin-Sanchez FJ, Jacob J, Herrero P, Alquezar A, Llauger L, Aguilo S, Martinez G, Rios J, Dominguez-Rodriguez A, Harjola VP, Muller C, Parissis J, Peacock WF, Llorens P (2018) Research Group on Acute Heart Failure of the Spanish Society of Emergency Medicine R. Short-term outcomes of heart failure patients with reduced and preserved ejection fraction after acute decompensation according to the final destination after emergency department care. Clin Res Cardiol. https://doi.org/10.1007/s00392-018-1237-z CrossRefPubMed Miro O, Gil VI, Martin-Sanchez FJ, Jacob J, Herrero P, Alquezar A, Llauger L, Aguilo S, Martinez G, Rios J, Dominguez-Rodriguez A, Harjola VP, Muller C, Parissis J, Peacock WF, Llorens P (2018) Research Group on Acute Heart Failure of the Spanish Society of Emergency Medicine R. Short-term outcomes of heart failure patients with reduced and preserved ejection fraction after acute decompensation according to the final destination after emergency department care. Clin Res Cardiol. https://​doi.​org/​10.​1007/​s00392-018-1237-z CrossRefPubMed
34.
Zurück zum Zitat Tschope C, Birner C, Bohm M, Bruder O, Frantz S, Luchner A, Maier L, Stork S, Kherad B, Laufs U (2018) Heart failure with preserved ejection fraction: current management and future strategies: Expert opinion on the behalf of the Nucleus of the “Heart Failure Working Group” of the German Society of Cardiology (DKG). Clin Res Cardiol 107(1):1–19CrossRefPubMed Tschope C, Birner C, Bohm M, Bruder O, Frantz S, Luchner A, Maier L, Stork S, Kherad B, Laufs U (2018) Heart failure with preserved ejection fraction: current management and future strategies: Expert opinion on the behalf of the Nucleus of the “Heart Failure Working Group” of the German Society of Cardiology (DKG). Clin Res Cardiol 107(1):1–19CrossRefPubMed
35.
Zurück zum Zitat Chau K, Girerd N, Magnusson M, Lamiral Z, Bozec E, Merckle L, Leosdottir M, Bachus E, Frikha Z, Ferreira JP, Despres JP, Rossignol P, Boivin JM, Zannad F (2018) Obesity and metabolic features associated with long-term developing diastolic dysfunction in an initially healthy population-based cohort. Clin Res Cardiol. https://doi.org/10.1007/s00392-018-1259-6 CrossRefPubMed Chau K, Girerd N, Magnusson M, Lamiral Z, Bozec E, Merckle L, Leosdottir M, Bachus E, Frikha Z, Ferreira JP, Despres JP, Rossignol P, Boivin JM, Zannad F (2018) Obesity and metabolic features associated with long-term developing diastolic dysfunction in an initially healthy population-based cohort. Clin Res Cardiol. https://​doi.​org/​10.​1007/​s00392-018-1259-6 CrossRefPubMed
36.
Zurück zum Zitat Sze S, Pellicori P, Kamzi S, Anton A, Clark AL (2018) Effect of beta-adrenergic blockade on weight changes in patients with chronic heart failure. Int J Cardiol 264:104–112CrossRefPubMed Sze S, Pellicori P, Kamzi S, Anton A, Clark AL (2018) Effect of beta-adrenergic blockade on weight changes in patients with chronic heart failure. Int J Cardiol 264:104–112CrossRefPubMed
38.
Zurück zum Zitat Streng KW, Voors AA, Hillege HL, Anker SD, Cleland JG, Dickstein K, Filippatos G, Metra M, Ng LL, Ponikowski P, Samani NJ, van Veldhusen DJ, Zwinderman AH, Zannad F, Damman K, van der Meer P, Lang CC (2018) Waist–hip ratio and mortality in heart failure. Eur J Heart Fail (In press) Streng KW, Voors AA, Hillege HL, Anker SD, Cleland JG, Dickstein K, Filippatos G, Metra M, Ng LL, Ponikowski P, Samani NJ, van Veldhusen DJ, Zwinderman AH, Zannad F, Damman K, van der Meer P, Lang CC (2018) Waist–hip ratio and mortality in heart failure. Eur J Heart Fail (In press)
39.
Zurück zum Zitat Ebong IA, Goff DC Jr, Rodriguez CJ, Chen H, Bertoni AG (2014) Mechanisms of heart failure in obesity. Obes Res Clin Pract 8(6):e540–e548CrossRef Ebong IA, Goff DC Jr, Rodriguez CJ, Chen H, Bertoni AG (2014) Mechanisms of heart failure in obesity. Obes Res Clin Pract 8(6):e540–e548CrossRef
40.
Zurück zum Zitat Backhaus T, Fach A, Schmucker J, Fiehn E, Garstka D, Stehmeier J, Hambrecht R, Wienbergen H (2018) Management and predictors of outcome in unselected patients with cardiogenic shock complicating acute ST-segment elevation myocardial infarction: results from the Bremen STEMI Registry. Clin Res Cardiol 107(5):371–379CrossRefPubMed Backhaus T, Fach A, Schmucker J, Fiehn E, Garstka D, Stehmeier J, Hambrecht R, Wienbergen H (2018) Management and predictors of outcome in unselected patients with cardiogenic shock complicating acute ST-segment elevation myocardial infarction: results from the Bremen STEMI Registry. Clin Res Cardiol 107(5):371–379CrossRefPubMed
43.
Zurück zum Zitat Fonarow GC, Srikanthan P, Costanzo MR, Cintron GB, Lopatin M, Committee ASA (2007) Investigators. An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry. Am Heart J 153(1):74–81CrossRefPubMed Fonarow GC, Srikanthan P, Costanzo MR, Cintron GB, Lopatin M, Committee ASA (2007) Investigators. An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry. Am Heart J 153(1):74–81CrossRefPubMed
44.
45.
Zurück zum Zitat Shah M, Patnaik S, Patel B, Ram P, Garg L, Agarwal M, Agrawal S, Arora S, Patel N, Wald J, Jorde UP (2018) Trends in mechanical circulatory support use and hospital mortality among patients with acute myocardial infarction and non-infarction related cardiogenic shock in the United States. Clin Res Cardiol 107(4):287–303CrossRefPubMed Shah M, Patnaik S, Patel B, Ram P, Garg L, Agarwal M, Agrawal S, Arora S, Patel N, Wald J, Jorde UP (2018) Trends in mechanical circulatory support use and hospital mortality among patients with acute myocardial infarction and non-infarction related cardiogenic shock in the United States. Clin Res Cardiol 107(4):287–303CrossRefPubMed
46.
Zurück zum Zitat Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, Group ESCSD (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37(27):2129–2200CrossRefPubMed Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, Group ESCSD (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37(27):2129–2200CrossRefPubMed
47.
Zurück zum Zitat Shah RV, Abbasi SA, Yamal JM, Davis BR, Barzilay J, Einhorn PT, Goldfine AB, Group ACR (2014) Impaired fasting glucose and body mass index as determinants of mortality in ALLHAT: is the obesity paradox real? J Clin Hypertens (Greenwich) 16(6):451–458CrossRef Shah RV, Abbasi SA, Yamal JM, Davis BR, Barzilay J, Einhorn PT, Goldfine AB, Group ACR (2014) Impaired fasting glucose and body mass index as determinants of mortality in ALLHAT: is the obesity paradox real? J Clin Hypertens (Greenwich) 16(6):451–458CrossRef
48.
Zurück zum Zitat Costanzo P, Cleland JG, Pellicori P, Clark AL, Hepburn D, Kilpatrick ES, Perrone-Filardi P, Zhang J, Atkin SL (2015) The obesity paradox in type 2 diabetes mellitus: relationship of body mass index to prognosis: a cohort study. Ann Intern Med 162(9):610–618CrossRefPubMed Costanzo P, Cleland JG, Pellicori P, Clark AL, Hepburn D, Kilpatrick ES, Perrone-Filardi P, Zhang J, Atkin SL (2015) The obesity paradox in type 2 diabetes mellitus: relationship of body mass index to prognosis: a cohort study. Ann Intern Med 162(9):610–618CrossRefPubMed
49.
Zurück zum Zitat Sinning C, Ojeda F, Wild PS, Schnabel RB, Schwarzl M, Ohdah S, Lackner KJ, Pfeiffer N, Michal M, Blettner M, Munzel T, Kempf T, Wollert KC, Kuulasmaa K, Blankenberg S, Salomaa V, Westermann D, Zeller T (2017) Midregional proadrenomedullin and growth differentiation factor-15 are not influenced by obesity in heart failure patients. Clin Res Cardiol 106(6):401–410CrossRefPubMed Sinning C, Ojeda F, Wild PS, Schnabel RB, Schwarzl M, Ohdah S, Lackner KJ, Pfeiffer N, Michal M, Blettner M, Munzel T, Kempf T, Wollert KC, Kuulasmaa K, Blankenberg S, Salomaa V, Westermann D, Zeller T (2017) Midregional proadrenomedullin and growth differentiation factor-15 are not influenced by obesity in heart failure patients. Clin Res Cardiol 106(6):401–410CrossRefPubMed
50.
Zurück zum Zitat Sandhu RK, Ezekowitz J, Andersson U, Alexander JH, Granger CB, Halvorsen S, Hanna M, Hijazi Z, Jansky P, Lopes RD, Wallentin L (2016) The ‘obesity paradox’ in atrial fibrillation: observations from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial. Eur Heart J 37(38):2869–2878CrossRefPubMed Sandhu RK, Ezekowitz J, Andersson U, Alexander JH, Granger CB, Halvorsen S, Hanna M, Hijazi Z, Jansky P, Lopes RD, Wallentin L (2016) The ‘obesity paradox’ in atrial fibrillation: observations from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial. Eur Heart J 37(38):2869–2878CrossRefPubMed
51.
Zurück zum Zitat Abdin A, Poss J, Fuernau G, Ouarrak T, Desch S, Eitel I, de Waha S, Zeymer U, Bohm M, Thiele H (2018) Revision: prognostic impact of baseline glucose levels in acute myocardial infarction complicated by cardiogenic shock-a substudy of the IABP-SHOCK II-trial. Clin Res Cardiol 107(6):517–523CrossRefPubMed Abdin A, Poss J, Fuernau G, Ouarrak T, Desch S, Eitel I, de Waha S, Zeymer U, Bohm M, Thiele H (2018) Revision: prognostic impact of baseline glucose levels in acute myocardial infarction complicated by cardiogenic shock-a substudy of the IABP-SHOCK II-trial. Clin Res Cardiol 107(6):517–523CrossRefPubMed
52.
Zurück zum Zitat Wang ZJ, Zhou YJ, Galper BZ, Gao F, Yeh RW, Mauri L (2015) Association of body mass index with mortality and cardiovascular events for patients with coronary artery disease: a systematic review and meta-analysis. Heart 101(20):1631–1638CrossRefPubMed Wang ZJ, Zhou YJ, Galper BZ, Gao F, Yeh RW, Mauri L (2015) Association of body mass index with mortality and cardiovascular events for patients with coronary artery disease: a systematic review and meta-analysis. Heart 101(20):1631–1638CrossRefPubMed
53.
Zurück zum Zitat Futter JE, Cleland JG, Clark AL (2011) Body mass indices and outcome in patients with chronic heart failure. Eur J Heart Fail 13(2):207–13CrossRefPubMed Futter JE, Cleland JG, Clark AL (2011) Body mass indices and outcome in patients with chronic heart failure. Eur J Heart Fail 13(2):207–13CrossRefPubMed
55.
Zurück zum Zitat Fu M, Ahrenmark U, Berglund S, Lindholm CJ, Lehto A, Broberg AM, Tasevska-Dinevska G, Wikstrom G, Agard A, Andersson B (2017) All investigators of the HRHFs. Adherence to optimal heart rate control in heart failure with reduced ejection fraction: insight from a survey of heart rate in heart failure in Sweden (HR-HF study). Clin Res Cardiol 106(12):960–973CrossRefPubMedPubMedCentral Fu M, Ahrenmark U, Berglund S, Lindholm CJ, Lehto A, Broberg AM, Tasevska-Dinevska G, Wikstrom G, Agard A, Andersson B (2017) All investigators of the HRHFs. Adherence to optimal heart rate control in heart failure with reduced ejection fraction: insight from a survey of heart rate in heart failure in Sweden (HR-HF study). Clin Res Cardiol 106(12):960–973CrossRefPubMedPubMedCentral
56.
Zurück zum Zitat Kenchaiah S, Pocock SJ, Wang D, Finn PV, Zornoff LA, Skali H, Pfeffer MA, Yusuf S, Swedberg K, Michelson EL, Granger CB, McMurray JJ, Solomon SD, Investigators C (2007) Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program. Circulation 116(6):627–36CrossRefPubMed Kenchaiah S, Pocock SJ, Wang D, Finn PV, Zornoff LA, Skali H, Pfeffer MA, Yusuf S, Swedberg K, Michelson EL, Granger CB, McMurray JJ, Solomon SD, Investigators C (2007) Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program. Circulation 116(6):627–36CrossRefPubMed
57.
Zurück zum Zitat Chan MM, Lam CS (2013) How do patients with heart failure with preserved ejection fraction die? Eur J Heart Fail 15(6):604–13CrossRefPubMed Chan MM, Lam CS (2013) How do patients with heart failure with preserved ejection fraction die? Eur J Heart Fail 15(6):604–13CrossRefPubMed
Metadaten
Titel
Body mass index and all-cause mortality in heart failure patients with normal and reduced ventricular ejection fraction: a dose–response meta-analysis
verfasst von
Jufen Zhang
Aine Begley
Ruth Jackson
Michael Harrison
Pierpaolo Pellicori
Andrew L. Clark
John G. F. Cleland
Publikationsdatum
27.06.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Research in Cardiology / Ausgabe 2/2019
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-018-1302-7

Weitere Artikel der Ausgabe 2/2019

Clinical Research in Cardiology 2/2019 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.